IVI’s Board of Trustees is delighted to welcome three new members: Dr. Nakorn Premsri, who began his 3-year term in May, and Yanchun Lily Li and Richard C. Henriques who will begin their service at the next Board meeting in November 2023. Together, they bring deep expertise in vaccine research and development, public health, international business, and finance, along with invaluable experience working with and within government, pharmaceutical companies, and philanthropies.
Dr. Nakorn Premsri represents the Government of Thailand on the IVI Board, which entrusts voting seats to all funding state parties. Dr. Premsri has been the Director of the National Vaccine Institute of Thailand since 2019 and previously held positions as the Director of the Bureau of Epidemiology and as the Director of the Office of the HIV/AIDS Vaccine Trial in the Thai Ministry of Public Health. He holds a Medical Degree from Chulalongkorn University with additional certifications in field epidemiology and preventive medicine.
For over 20 years, Yanchun Lily Li has co-founded, managed, and advised companies in the pharmaceutical, blockchain, and consulting industries. She is particularly accomplished in connecting businesses between China and the U.S. and holds a special interest in promoting international diplomacy. Li is the founder and chairperson of the Harvard Wealth Strategy and Management LLC in New York, chairperson of the UBI Global Blockchain Technology Inc. in Hong Kong, and sits on both the Women’s Leadership Board and the Dean’s Council at Harvard Kennedy School.
As the former Chief Financial Officer at the Bill & Melinda Gates Foundation and former Senior Vice-President of Finance and Corporate Controller at Merck & Co., Inc., Richard C. Henriques brings extensive knowledge of financial operations and governance to IVI. Henriques is a Senior Fellow at the Center for High Impact Philanthropy at the University of Pennsylvania and currently holds board positions at 8 companies and organizations ranging from the bio-pharmaceutical industry to science education and historic preservation. He chairs the audit committees at Arbutus Biopharma, Cabaletta, EMulate, and the Franklin Institute.
“The IVI Board of Trustees is privileged to welcome Dr. Nakorn Premsri, Yanchun Lily Li, and Richard Henriques. Their multifaceted and varied backgrounds will help guide IVI’s growth and strategy as both a cutting-edge research institute with industry partners around the world and a mission-driven international organization with member states,” said George Bickerstaff, Chair of IVI’s Board of Trustees.